Survival following radiotherapy in young women with localized early ‐stage breast cancer according to molecular subtypes
ConclusionsRT could offer significant survival benefit in luminal ‐A, luminal‐B, and especially HER2‐enriched young early‐stage breast cancer female patients. The results enabled clinicians to predict the benefits of RT and improve evidence‐based treatment for breast cancer patients.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Qi ‐Qi Liu,
He‐Fen Sun,
Xue‐Li Yang,
Meng‐Ting Chen,
Yang Liu,
Yang Zhao,
Yuan‐Yuan Zhao,
Wei Jin Tags: ORIGINAL RESEARCH Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Epidemiology | HER2 | Hormones | Men | Study | Women